Segment Information

6 Months Ended

Jun. 30, 2013

Segment Information

12. Segment Information

The company’s management considers its business to be a single segment entity—the manufacture and sale of medical devices. The company’s products generally share similar distribution channels and customers. The company designs, develops, manufactures, packages, distributes and sells medical, surgical, diagnostic and patient care devices. The company sells a broad range of products to hospitals, individual healthcare professionals, extended care health facilities and alternate site facilities on a global basis. In general, the company’s products are intended to be used once and then discarded or either temporarily or permanently implanted. The company’s chief operating decision makers evaluate their various global product portfolios on a net sales basis and generally evaluate profitability and associated investment on an enterprise-wide basis due to shared geographic infrastructures.

Net sales based on the location of external customers by geographic region are:

	Quarter Ended June 30,				Six Months Ended June 30,
	2013		2012		2013		2012
(dollars in millions)
United States	$	497.6	$	490.0	$	996.1	$	986.2
Europe(a)		123.0		123.8		239.8		240.5
Japan		40.0		41.5		80.0		80.6
Other(a)		99.3		87.3		184.3		165.3
	$	759.9	$	742.6	$	1,500.2	$	1,472.6

(a) Beginning in 2013, certain emerging markets in Europe are included in the “other” geographic region. Prior year amounts have been reclassified to conform to the current year presentation.

Total net sales by product group category are:

	Quarter Ended June 30,				Six Months Ended June 30,
	2013		2012		2013		2012
(dollars in millions)
Vascular	$	212.2	$	221.3	$	415.4	$	430.5
Urology		191.7		188.8		380.5		373.9
Oncology		214.1		199.1		421.2		398.0
Surgical Specialties		120.0		111.4		240.3		226.1
Other		21.9		22.0		42.8		44.1
	$	759.9	$	742.6	$	1,500.2	$	1,472.6